Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial.
Gu C, Wang Z, Lin T, Liu Z, Han W, Zhang X, Liang C, Liu H, Yu Y, Xu Z, Liu S, Wang J, Jia L, Yao X, Liao W, Fu C, Tan Z, He G, Zhu G, Fan R, Yang W, Chen X, Liu Z, Zhong L, Shi B, Ding D, Chen S, Wei J, Yao X, Chen M, Lu Z, Xie Q, Hu Z, Wang Y, Guo H, Fan T, Liang Z, Chen P, Wang W, Xu T, Li C, Xing J, Liao H, He D, Wu Z, Yu J, Feng Z, Yang M, Dou Q, Zeng Q, Li Y, Gou X, Zhou G, Wang X, Zhu R, Zhang Z, Zhang B, Tan W, Qu X, Sun H, Gan T, Ye D. Gu C, et al. Among authors: shi b. Chin Med J (Engl). 2023 May 20;136(10):1207-1215. doi: 10.1097/CM9.0000000000002638. Epub 2023 Apr 3. Chin Med J (Engl). 2023. PMID: 37010251 Free PMC article. Clinical Trial.
Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT).
Sheng X, Ye D, Zhou A, Yao X, Luo H, He Z, Wang Z, Zhao Y, Ji Z, Zou Q, He C, Guo J, Tu X, Liu Z, Shi B, Liu B, Chen P, Wei Q, Hu Z, Zhang Y, Jiang K, Zhou F, Wu D, Fu C, Li X, Wu B, Wang L, Qin S, Li G, Liu Y, Guo H, Chen K, Zhang D, Wang G, Ding L, Wang Y, Yuan X, Guo J. Sheng X, et al. Among authors: shi b. Eur J Cancer. 2023 Jan;178:205-215. doi: 10.1016/j.ejca.2022.10.025. Epub 2022 Nov 1. Eur J Cancer. 2023. PMID: 36459768 Free article. Clinical Trial.
Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials.
Sheng X, Wang L, He Z, Shi Y, Luo H, Han W, Yao X, Shi B, Liu J, Hu C, Liu Z, Guo H, Yu G, Ji Z, Ying J, Ling Y, Yu S, Hu Y, Guo J, Fang J, Zhou A, Guo J. Sheng X, et al. Among authors: shi b, shi y. J Clin Oncol. 2024 Apr 20;42(12):1391-1402. doi: 10.1200/JCO.22.02912. Epub 2023 Nov 21. J Clin Oncol. 2024. PMID: 37988648 Clinical Trial.
Nomogram to predict the presence of PSMA-negative but FDG-positive lesion in castration-resistant prostate cancer: a multicenter cohort study.
Pan J, Zhang T, Chen S, Bu T, Zhao J, Ni X, Shi B, Gan H, Wei Y, Wang Q, Wang B, Wu J, Song S, Wang F, Liu C, Ye D, Zhu Y. Pan J, et al. Among authors: shi b. Ther Adv Med Oncol. 2024 Jan 6;16:17588359231220506. doi: 10.1177/17588359231220506. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38188464 Free PMC article.
Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer.
Chen N, Wang Z, Chen M, Ma Q, He Y, Wang Y, Li X, Qiu M, Shi L, Zhu S, Xie Q, Liu X, Shi B, Lin G, Yang W, Liao Y, Zhang H, Wang S, Li J, Wang S, Dong L, Chen H, Lu J, Cheng Y, Zhang X, Ma L, Zhou L, Wang H, Li S, Ye D. Chen N, et al. Among authors: shi b, shi l. Cancer Biol Med. 2024 Feb 5;20(12):1047-59. doi: 10.20892/j.issn.2095-3941.2023.0335. Cancer Biol Med. 2024. PMID: 38318809 Free PMC article.
A multicenter uroflowmetry study of healthy women in China.
Liu X, Meng L, Wang J, Ma T, Shi B, Huang H, Wang Q, Chen M, Liao L, Shen H, Wei Z, Xiao Y, Pan T, Ren J, Zhang P, Tian X, Zhang Y. Liu X, et al. Among authors: shi b. Chin Med J (Engl). 2024 Apr 10. doi: 10.1097/CM9.0000000000003100. Online ahead of print. Chin Med J (Engl). 2024. PMID: 38602088 No abstract available.
Neoadjuvant therapy with camrelizumab plus gemcitabine and cisplatin for patients with muscle-invasive bladder cancer: A multi-center, single-arm, phase 2 study.
Han S, Ji Z, Jiang J, Fan X, Ma Q, Hu L, Zhang W, Ping H, Wang J, Xu W, Shi B, Wang W, Wang H, Wang H, Chen S, Hu H, Guo J, Zhang S, Jiang S, Zhou Q, Xing N. Han S, et al. Among authors: shi b. Cancer Med. 2023 Jun;12(11):12106-12117. doi: 10.1002/cam4.5900. Epub 2023 Apr 6. Cancer Med. 2023. PMID: 37021811 Free PMC article. Clinical Trial.
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy.
Wu Z, Chen H, Chen Q, Ge S, Yu N, Campi R, Gómez Rivas J, Autorino R, Rouprêt M, Psutka SP, Mehrazin R, Porpiglia F, Bensalah K, Black PC, Mir MC, Minervini A, Djaladat H, Margulis V, Bertolo R, Caliò A, Carbonara U, Amparore D, Borregales LD, Ciccarese C, Diana P, Erdem S, Marandino L, Marchioni M, Muselaers CHJ, Palumbo C, Pavan N, Pecoraro A, Roussel E, Warren H, Pandolfo SD, Chen R, Zhou W, Zhai W, He M, Li Y, Han B, Wan J, Zeng X, Yan J, Fu Y, Ji C, Fan X, Zhang G, Zhao C, Jing T, Wang A, Feng C, Zhao H, Sun D, Wang L, Tai S, Zhang C, Chen S, Liu Y, Xu Z, Wang H, Gao J, Wang F, Cheng J, Miao H, Rao Q, Wang J, Xu N, Wang G, Liang C, Liu Z, Xia D, Jiang J, Zu X, Chen M, Guo H, Qin W, Wang Z, Xue W, Shi B, Zhou X, Wang S, Zheng J, Ge J, Feng X, Li M, Chen C, Qu L, Wang L; REMEMBER Consortium and the European Association of Urology Young Academic Urologists Renal Cancer Working Group. Wu Z, et al. Among authors: shi b. Eur Urol Oncol. 2024 Feb;7(1):112-121. doi: 10.1016/j.euo.2023.06.006. Epub 2023 Jul 18. Eur Urol Oncol. 2024. PMID: 37468393
Development and validation of a prognostic model incorporating tumor thrombus grading for nonmetastatic clear cell renal cell carcinoma with tumor thrombus: A multicohort study.
Qu L, Chen H, Chen Q, Ge S, Jiang A, Yu N, Zhou Y, Kunc M, Zhou Y, Feng X, Zhai W, Wu Z, He M, Li Y, Chen R, Han B, Zeng X, Fu Y, Ji C, Fan X, Zhang G, Zhao C, Jing T, Feng C, Zhao H, Sun D, Wang L, Tai S, Zhang C, Chen S, Liu Y, Wang H, Gao J, Gu Y, Miao H, Zhao T, Yi X, Tang C, Fu D, He H, Rao Q, Zhou W, Xu N, Wang G, Liang C, Liu Z, Xia D, Zu X, Chen M, Guo H, Qin W, Wang Z, Xue W, Shi B, Wang S, Zheng J, Chen C, Zapała Ł, Ge J, Wang L. Qu L, et al. Among authors: shi b. MedComm (2020). 2023 Jul 20;4(4):e300. doi: 10.1002/mco2.300. eCollection 2023 Aug. MedComm (2020). 2023. PMID: 37484972 Free PMC article.
5,129 results